No results for ‘’
Gian Lifecare Ltd
NSE: BSE: 542918
â‚ą4.77
(0%)
Sat, 12 Sept 2026, 03:40 pm
Market Cap (in Cr)4.93
PE Ratio0
Dividend0
Health Services
Medical/Nursing Services
24.5KGian Lifecare Analysis
dividend
- Unable to evaluate Gian Life Care's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Gian Life Care's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Gian Life Care is profitable, therefore cash runway is not a concern.
- Gian Life Care is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (225.8%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 1.1x debt.
- Gian Life Care's cash and other short term assets cover its long term commitments.
- Interest payments on debt are well covered by earnings (EBIT is 6.4x coverage).
- Gian Life Care's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Gian Life Care's level of debt (2878.4%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
- The average tenure for the Gian Life Care board of directors is less than 3 years, this suggests a new board.
- The average tenure for the Gian Life Care management team is less than 2 years, this suggests a new team.
misc
- Gian Life Care is not covered by any analysts.
- Gian Life Care's last earnings update was 344 days ago.
past
- Gian Life Care used its assets less efficiently than the IN Healthcare industry average last year based on Return on Assets.
- Whilst Gian Life Care made outstanding use of shareholders’ funds last year (Return on Equity greater than 40%), this is metric is skewed due to its high level of debt.
value
- Gian Life Care's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Gian Life Care's share price is below the future cash flow value, and at a substantial discount (> 40%).
- BSE:542918 is up 6.1% along with the Healthcare industry (5.4%) over the past month.
- Gian Life Care is overvalued based on assets compared to the IN Healthcare industry average.
- Gian Life Care is overvalued based on earnings compared to the IN Healthcare industry average.
- Gian Life Care is overvalued based on earnings compared to the India market.
- BSE:542918 is up 6.1% underperforming the market in India which returned 8% over the past month.